Aurora Cannabis and Tilray are driving market growth and leading innovations in European cannabis therapies.
2 reports, 2 independent
Updated Aug 19
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Aurora Cannabis and Tilray are driving market growth and leading innovations in European cannabis therapies.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Both companies are dealing with market headwinds while German guidance affects the sector.1 source
Both Aurora Cannabis and Tilray are noted for driving market growth and innovation in Europe.1 source
Keep exploring
The entities involved
-
CanniMed
Canadian public licensed producer of medical cannabis
-
Europe
terrestrial continent located in north-western Eurasia
-
Tilray
pharmaceutical and cannabis company
Related events
Coverage
Newest first; wire copies grouped- tickerreport.com
- GlobeNewswire$80 Bn Medical Marijuana Markets - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2032 The global medical marijuana market is set to transform healthcare, with predicted growt